Liberator Medical (LBMH) Stock Price, News & Analysis

Company Overview

Liberator Medical Holdings, Inc. is a medical device company headquartered in Charlotte, North Carolina, that specializes in advanced regenerative healing solutions for burn and wound care. The company focuses on the design, development and commercialization of tissue fixation and bioactive adhesion products that aim to improve the efficiency and outcomes of skin graft procedures.

The company’s flagship offering is Panafil Bio-Active Tissue Adhesive, a liquid adhesive cleared by the U.S. Food and Drug Administration for use in mesh and sheet autograft fixation. Panafil is designed to reduce operative time and provide uniform graft adherence without the need for staples or sutures, while supporting the body’s natural healing processes. In addition to its core adhesive product, Liberator Medical is developing complementary hemostatic and wound-healing adjuncts to broaden its portfolio of burn and wound care solutions.

Liberator Medical serves a network of burn centers, hospitals and wound care clinics primarily across the United States, with select international distribution in Europe. The company works with clinical partners, surgeons and distributors to integrate its products into standard burn treatment protocols and to pursue expanded indications in surgical and trauma settings. By focusing on innovative, easy-to-use technologies, Liberator Medical aims to address unmet needs in graft fixation and to support improved patient outcomes in burn and reconstructive surgery.

Key Stats

• Today's Range: $3.35 to $3.35
• 50-Day Range: $3.35 to $3.35
• 52-Week Range: $1.96 to $3.90
• Volume: N/A
• Average Volume: 173,892 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LBMH Stock Analysis - Frequently Asked Questions

How have LBMH shares performed this year?

Liberator Medical's stock was trading at $3.35 at the beginning of 2025. Since then, LBMH shares have increased by 0.0% and is now trading at $3.35.

How were Liberator Medical's earnings last quarter?

Liberator Medical Holdings, Inc. (NYSEMKT:LBMH) released its quarterly earnings results on Monday, February, 9th. The medical instruments supplier reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05.

How do I buy shares of Liberator Medical?

Shares of LBMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Liberator Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Liberator Medical investors own include Avid Bioservices (CDMO), Extra Space Storage (EXR), (BBEPQ) (BBEPQ), Inovio Pharmaceuticals (INO), Achieve Life Sciences (ACHV), Calithera Biosciences (CALA) and Compugen (CGEN).

Company Calendar

• Last Earnings: 2/09/2015
• Today: 10/08/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEMKT
• Sector: Manufacturing
• Industry: Electronic Computer Manufacturing
• Sub-Industry: Retail
• Current Symbol: NYSEMKT:LBMH
• CIK: N/A
• Web: www.liberatormedical.com
• Phone: +1-772-2872414
• Fax: N/A
• Employees: 338
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A